Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery

Introduction: Surgery is the cornerstone of ovarian cancer treatment. However, surgery and perioperative inflammation have been described as potentially pro-metastagenic. In various animal models and other human cancers, intraoperative administration of non-steroidal anti-inflammatory drugs (NSAIDs)...

Full description

Bibliographic Details
Main Authors: Mathieu Luyckx, Céline Verougstraete, Mathieu Jouret, Kiswendsida Sawadogo, Marc Waterkeyn, Frédéric Grandjean, Jean-Paul Van Gossum, Nathanael Dubois, Vincent Malvaux, Lucie Verreth, Pascale Grandjean, Pascale Jadoul, Charlotte Maillard, Amandine Gerday, Audrey Dieu, Patrice Forget, Jean-François Baurain, Jean-Luc Squifflet
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Journal of Clinical Medicine
Subjects:
ovarian cancer
oncological surgery
peri operative inflammation
NSAID
Online Access:https://www.mdpi.com/2077-0383/13/6/1546

Similar Items

Similar Items